Apple Watch gets FDA clearance for use in arrhythmia detection
The latest iteration of the Apple Watch, dubbed Series 4 gets FDA clearance for use in detection and notification of atrial fibrillation and other arrhythmias. It generates a single-lead ECG without any special band or third-party add-on. Instead, a user touches a finger to electrodes built into the crown and a new electrical heart rate sensor in the back crystal provides the other contact. Alerts are sent when abnormal rhythms are detected or when heart rates go above or below preset thresholds. R
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies